377 related articles for article (PubMed ID: 17110812)
1. Mortality in elderly dementia patients treated with risperidone.
Haupt M; Cruz-Jentoft A; Jeste D
J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
[TBL] [Abstract][Full Text] [Related]
2. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
4. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
[TBL] [Abstract][Full Text] [Related]
5. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
6. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
Lawlor BA
J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
[TBL] [Abstract][Full Text] [Related]
8. The risk of death among adult participants in trials of antipsychotic drugs in schizophrenia.
Isaac M; Koch A
Eur Neuropsychopharmacol; 2010 Mar; 20(3):139-45. PubMed ID: 20053539
[TBL] [Abstract][Full Text] [Related]
9. Elderly dementia patients and neuroleptics: excess mortality.
Prescrire Int; 2010 Oct; 19(109):210-2. PubMed ID: 21180375
[TBL] [Abstract][Full Text] [Related]
10. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
Ballard CG; Margallo-Lana ML
J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968
[TBL] [Abstract][Full Text] [Related]
11. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.
Gareri P; De Fazio P; Manfredi VG; De Sarro G
J Clin Psychopharmacol; 2014 Feb; 34(1):109-23. PubMed ID: 24158020
[TBL] [Abstract][Full Text] [Related]
12. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study.
Raivio MM; Laurila JV; Strandberg TE; Tilvis RS; Pitkälä KH
Am J Geriatr Psychiatry; 2007 May; 15(5):416-24. PubMed ID: 17463191
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: a hospital-based, retrospective, cohort study.
Chan MC; Chong CS; Wu AY; Wong KC; Dunn EL; Tang OW; Chan WF
Int J Geriatr Psychiatry; 2010 Apr; 25(4):362-70. PubMed ID: 19650162
[TBL] [Abstract][Full Text] [Related]
14. Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
Wang PS; Schneeweiss S; Avorn J; Fischer MA; Mogun H; Solomon DH; Brookhart MA
N Engl J Med; 2005 Dec; 353(22):2335-41. PubMed ID: 16319382
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
Paleacu D; Barak Y; Mirecky I; Mazeh D
Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety of risperidone.
Davidson M
J Clin Psychiatry; 2001; 62 Suppl 21():26-8. PubMed ID: 11584985
[TBL] [Abstract][Full Text] [Related]
17. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
De Deyn PP; Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
[No Abstract] [Full Text] [Related]
19. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
[TBL] [Abstract][Full Text] [Related]
20. The effect of risperidone on nursing burden associated with caring for patients with dementia.
Frank L; Kleinman L; Ciesla G; Rupnow MF; Brodaty H
J Am Geriatr Soc; 2004 Sep; 52(9):1449-55. PubMed ID: 15341545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]